RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression.
Nagamine H, Yashiro M, Yoshimoto N, Izumi M, Sugimoto A, Nakahama K, Ogawa K, Matsumoto Y, Sawa K, Tani Y, Kaneda H, Mitsuoka S, Yamada K, Watanabe T, Aasai K, Fukumura K, Mayeda A, Kawaguchi T.
Nagamine H, et al. Among authors: fukumura k.
Anticancer Res. 2023 Oct;43(10):4663-4672. doi: 10.21873/anticanres.16662.
Anticancer Res. 2023.
PMID: 37772582